跳至主要内容
临床试验/EUCTR2014-003834-21-NL
EUCTR2014-003834-21-NL进行中(未招募)1 期

Effectiveness of penfluridol (oral long acting neuroleptic) as compared to second generation oral neuroleptics in psychotic disorder patients: an open label randomized controlled trial. - The One for Seven Study

Erasmus Medical Center Rotterdam0 个研究点目标入组 180 人开始时间: 2015年4月1日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
180

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • In order to be eligible to participate in this study, a subject must meet all of the following criteria:
  • 1. age 18-65 years
  • 2. psychotic disorder, including schizophrenia, schizoaffective disorder, delusional disorder or psychosis not otherwise specified
  • 3. treatment on an outpatient basis (at the start of the study)
  • 4. psychiatrist treating the patient decides that it is appropriate (based on clinical judgement, guidelines, history and symptoms of the patient) to prescribe either penfluridol, olanzapine or risperidone and that there a no decisive contra-indications
  • 5. patient is willing to use oral neuroleptic treatment, including penfluridol, olanzapine or risperidone
  • 6. able to give informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 180
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • A potential subject who meets any of the following criteria will be excluded from participation in this study:
  • 1. judicial order stating that taking medication is obliged
  • 2. patient did use penfluridol during the previous six months
  • 3. serious and unstable medical condition
  • 4. insufficient proficiency in Dutch language
  • 5. women who are pregnant

研究者

发起方
Erasmus Medical Center Rotterdam

相似试验

撤回
3 期
Effectiveness of penfluridol (oral long acting neuroleptic) as compared to second generation oral neuroleptics in psychotic disorder patients: an open label randomized controlled trial.Psychotic disorder10039628
NL-OMON44089Erasmus MC, Universitair Medisch Centrum Rotterdam180
暂停
不适用
'Effectiveness of Penfluridol (long acting neuroleptic) as compared to second generation oral neuroleptics (olanzapine and risperidone) in psychotic disorder patients: an open label randomized controlled trial'
NL-OMON26965Erasmus University Medical Center, RotterdamPsychiatry Department180
进行中(未招募)
1 期
Standard-armed controlled study to assess the impact of oral Pirfenidone for progressive, non-IPF Lung Fibrosis (RELIEF)1.Fibrotic NSIP., 2.Chronic Hypersensitivity Pneumonitis 3. Lung fibrosis associated with collagen / vascular diseases, 4.Asbestos-induced lung fibrosisMedDRA version: 20.0Level: LLTClassification code 10022612Term: Interstitial lung fibrosisSystem Organ Class: 100000004855MedDRA version: 20.0Level: LLTClassification code 10035754Term: Pneumonitis hypersensitivitySystem Organ Class: 100000004855MedDRA version: 20.0Level: LLTClassification code 10025088Term: Lung fibrosisSystem Organ Class: 100000004855MedDRA version: 20.0Level: LLTClassification code 10022617Term: Interstitial pneumoniaSystem Organ Class: 100000004855
EUCTR2014-000861-32-DEJustus Liebig Universität Giessen374
进行中(未招募)
2 期
Exploring Efficacy and Safety of oral Pirfenidone for progressive, non-IPF Lung Fibrosis (RELIEF) -A randomized, double-blind, placebo-controlled, parallel group,multi-center, phase II trialJ84.1J68.4Other interstitial pulmonary diseases with fibrosisChronic respiratory conditions due to chemicals, gases, fumes and vapours
DRKS00009822Justus-Liebig Universität Giessen127
已完成
2 期
Effectiveness of pentoxifylline in contrast induced nephropathyRenal failureContrast Nephropathy.N17, N18,
IRCT2015102624713N1Vice chancellor for research,Zahedan University of Medical Sciences60